Treats recurrent episodes Genital herpes. ANDA 91114, held by Aurobindo Pharma Ltd. Famciclovir.
As of Nov 16, 2026, ANDA 91114 (Famciclovir), held by Aurobindo Pharma Ltd, was first approved by FDA on Mar 21, 2011, with 6 approved supplements and 0 published complete response letters.
Famciclovir, a prodrug of penciclovir, is a deoxynucleoside analog DNA polymerase inhibitor indicated for: Immunocompetent Adult Patients Herpes labialis (cold sores) Treatment of recurrent episodes Genital herpes Treatment of recurrent episodes Suppressive therapy of recurrent episodes Herpes zoster (shingles) Human Immunodeficiency Virus (HIV)-Infected Adult Patients Treatment of recurrent episodes of orolabial or genital herpes Limitation of Use The efficacy and safety of famciclovir tablets have not been established for: Patients with first episode of genital herpes Patients with ophthalmic zoster Immunocompromised patients other than for the treatment of recurrent episodes of orolabial …
| Date | Submission | Status | Documents |
|---|---|---|---|
| Mar 21, 2011 | Original application | Approved | None posted |
| Famciclovir125MG · tablet;oral | Famciclovir | Rx |
| Famciclovir250MG · tablet;oral | Famciclovir | Rx |
| Famciclovir500MG · tablet;oral | Famciclovir | Rx |
| Jul 8, 2019 | Supplement 8Labeling · Standard review | Approved | None posted |
| Jul 8, 2019 | Supplement 9Labeling · Standard review | Approved | None posted |
| Mar 24, 2016 | Supplement 4Labeling · Standard review | Approved | None posted |
| Mar 24, 2016 | Supplement 5Labeling · Standard review | Approved | None posted |
| Jul 23, 2013 | Supplement 3Labeling · Standard review | Approved | None posted |
| May 30, 2013 | Supplement 2Labeling | Approved | None posted |
| Mar 21, 2011 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters